RxDoctor Payments Data

Gilbert Kliman

Ophthalmology · Menlo Park, CANPI 1578771671

Payments from drug & device makers

What this record shows

The money is spread across several categories — ownership interests (43.2%), royalties or licence payments and speaking fees — rather than concentrated in one kind of arrangement. Glaukos Corporation accounts for 99.9% of it on its own, with 4 other manufacturers making up the rest. Among ophthalmology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,522,731in general payments, 2019–2025

Across 49 payments — averaging $31,076 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Glaukos Corporation$1.5M
  • Carl Zeiss Meditec, Inc.$523
  • Alcon$278
  • Johnson & Johnson Surgical Vision, Inc.$171
  • Johnson & Johnson Vision Care, Inc.$31

What the payments were for

  • Royalty or licence$428,98928%
  • Consulting fees$90,0006%
  • Speaking & faculty fees$331,50022%
  • Travel & lodging$13,8201%
  • Food & beverage$1,1230%
  • Ownership interest$657,29943%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,522,731 in reported general payments places this provider in the 95th percentile of 2,513 ophthalmology providers in California.

See all ophthalmology providers in California

Other ophthalmology in Menlo Park

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →